Source comparison
No-DAC vs DAC Formulations for Sleep Protocols
CJC-1295 exists in two formulations with fundamentally different pharmacokinetics. No-DAC CJC-1295 (also called Modified GRF 1-29) has a plasma half-life of approximately 30 minutes, producing a sharp GH pulse that peaks 20–40 minutes post-injection and return
This comparison does not assign a generated winner or score.
- CJC-1295 exists in two formulations with fundamentally different pharmacokinetics. No-DAC CJC-1295 (also called Modified GRF 1-29) has a plasma half-life of approximately 30 minutes, producing a sharp GH pulse that peaks 20–40 minutes post-injection and returns to baseline within 2–3 hours. DAC-conjugated CJC-1295 (Drug Affinity Complex) binds to serum albumin, extending half-life to 6–8 days and maintaining elevated baseline GH for up to two weeks per dose. For sleep research, no-DAC is the preferred formulation because it allows precise temporal control. You can target the first or second nocturnal GH pulse specifically. DAC formulations elevate baseline GH continuously, which sustains IGF-1 elevation (useful for tissue repair studies) but reduces the amplitude of individual pulses due to negative feedback at the hypothalamic level.
- A comparative study published in Endocrine Reviews (2025) found that DAC CJC-1295 at 2mg weekly increased mean 24-hour GH by 110% but reduced nocturnal pulse amplitude by 18% due to somatostatin upregulation. No-DAC at 300mcg pre-sleep didn't change mean GH but increased peak nocturnal pulse by 340%, with corresponding increases in Stage 3 NREM duration. The mechanistic difference: pulsatile GH drives adenosine receptor downregulation in the basal forebrain, the pathway linked to slow-wave sleep depth. Sustained elevation doesn't engage this pathway with the same intensity. If your protocol targets sleep architecture specifically, no-DAC formulations provide better control. If studying systemic anabolic effects with secondary sleep outcomes, DAC formulations reduce injection frequency while maintaining baseline elevation.